Last reviewed · How we verify
injection of NaCl 0.9%
This drug works by replenishing fluids and electrolytes in the body.
This drug works by replenishing fluids and electrolytes in the body. Used for Fluid replacement in patients with dehydration or hypovolemia.
At a glance
| Generic name | injection of NaCl 0.9% |
|---|---|
| Sponsor | Assistance Publique - Hôpitaux de Paris |
| Drug class | Electrolyte solution |
| Modality | Small molecule |
| Therapeutic area | Fluid and electrolyte management |
| Phase | Phase 3 |
Mechanism of action
It does this by providing a solution of sodium chloride that is isotonic to human blood, allowing for the replacement of lost fluids and electrolytes without causing an osmotic imbalance.
Approved indications
- Fluid replacement in patients with dehydration or hypovolemia
Common side effects
- Hypersensitivity reactions
Key clinical trials
- PRP Injection Into the Sacroiliac Joint After Ipsilateral THA: Effects on Early Recovery and Function (SIJ-THA Randomized Trial) (NA)
- Endorotor Resection In Refractory Barrett's Dysplasia Patients (NA)
- Magnesium Supplementation in Advanced Non-small Cell Lung Cancer (NSCLC) (PHASE2, PHASE3)
- Tirzepatide in MetALD (PHASE2)
- FAP-targeted PET/NIR in Lung Malignant Tumors
- Thumb Base Osteoarthritis: Ultrasound-guided Platelet-rich Plasma Versus Placebo Injection (PHASE2)
- Safety Evaluation of PfSPZ Vaccine in Pregnant Women in Mali (MalVIP1) (PHASE1)
- SMILE Trial - Imaging Sub-Study
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- injection of NaCl 0.9% CI brief — competitive landscape report
- injection of NaCl 0.9% updates RSS · CI watch RSS
- Assistance Publique - Hôpitaux de Paris portfolio CI